ALB and metabolic syndrome: Increased albuminuria, defined as urine albumin-to-creatinine ratio (UACR) ≥ 30–300 mg/g [1], is a well-established early marker of chronic kidney disease (CKD) and a risk factor for cardiovascular disease (CVD) and cardiovascular mortality as well as all-cause mortality in patients with metabolic syndrome (MetS) [2,3,4,5].